Trial intelligence / Profile preview

Curcumin organogel for osteoarthritis treatment

IRCT20220531055045N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in osteoarthritis (OA), sponsored by Shiraz University of Medical Sciences. Started Jun 2022; status: completed.

02

Drugs

curcumin
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20220531055045N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220531055045N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call